Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

NCT04663100 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.

NCT NCT04663100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04663100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
Lead sponsor
University of Tennessee
Phase
Not applicable
Overall status
Unknown status
Start date
February 8, 2021
Completion date
December 31, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, chronic myeloid leukemia, multiple chronic conditions, multiple myeloma